Two sides to supramolecular drug delivery systems
Although still in its infancy, there is a rapidly increasing interest in the development of supramolecular drug delivery systems (SDDSs). As chemists, the most challenging task ahead of us is to narrow the gap between SDDSs development in the lab, and clinical drug carriers. Only then
will we achieve our ultimate goal of the successful translation of SDDSs to life saving medicines.
Keywords: Supramolecular nanocarriers; drug delivery; non-covalent interactions; stimuli-responsiveness
Document Type: Research Article
Affiliations: School of Chemistry and Chemical Engineering, Collaborative Innovation Center of Chemistry for Life Sciences, Nanjing University, Nanjing, China
Publication date: 03 August 2018
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content